Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hide

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Microbes and Infection|September 28, 2010
Canine visceral leishmaniasis caused by Leishmania infantum in Senegal: risk of emergence in humans?B Faye, A L Bañuls, B Bucheton, et al.
Allergy|January 11, 2018
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and updateM Maurer, M Magerl, I Ansotegui, et al.
Arerugi = [Allergy]|March 17, 2023
M Maurer, M Magerl, I Ansotegui, et al.
Allergy|October 8, 2024
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE studyR Soegiharto, M Alizadeh Aghdam, J A Sørensen, et al.
Allergy|May 3, 2014
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateT Zuberbier, W Aberer, R Asero, et al.
Allergy|June 6, 2014
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2024
The Chronic Angioedema Registry (CARE): Rationale, Methods and ImplementationT Buttgereit, F Aulenbacher, A Gutsche, et al.
Allergy|January 17, 2018
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Arerugi = [Allergy]|May 24, 2023
M Maurer, M Magerl, S Betschel, et al.
Arerugi = [Allergy]|September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Microbes and Infection|September 28, 2010
Canine visceral leishmaniasis caused by Leishmania infantum in Senegal: risk of emergence in humans?B Faye, A L Bañuls, B Bucheton, et al.
Allergy|January 11, 2018
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and updateM Maurer, M Magerl, I Ansotegui, et al.
Arerugi = [Allergy]|March 17, 2023
M Maurer, M Magerl, I Ansotegui, et al.
Allergy|October 8, 2024
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE studyR Soegiharto, M Alizadeh Aghdam, J A Sørensen, et al.
Allergy|May 3, 2014
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateT Zuberbier, W Aberer, R Asero, et al.
Allergy|June 6, 2014
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2024
The Chronic Angioedema Registry (CARE): Rationale, Methods and ImplementationT Buttgereit, F Aulenbacher, A Gutsche, et al.
Allergy|January 17, 2018
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Arerugi = [Allergy]|May 24, 2023
M Maurer, M Magerl, S Betschel, et al.
Arerugi = [Allergy]|September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Pageof 9